LEADER 03579oam  2200673I  450 
001 9910780603203321
005 20230601144458.0
010   $a0-429-19115-4
010   $a1-4200-2029-3
024 7 $a10.3109/9781420020298
035   $a(CKB)2440000000014258
035   $a(EBL)1405525
035   $a(SSID)ssj0000377516
035   $a(PQKBManifestationID)11278157
035   $a(PQKBTitleCode)TC0000377516
035   $a(PQKBWorkID)10337989
035   $a(PQKB)11225017
035   $a(MiAaPQ)EBC1405525
035   $a(MiAaPQ)EBC863286
035   $a(Au-PeEL)EBL1405525
035   $a(CaPaEBR)ebr10231554
035   $a(CaONFJC)MIL741292
035   $a(OCoLC)794663351
035   $a(OCoLC)858014450
035   $a(Au-PeEL)EBL863286
035   $a(EXLCZ)992440000000014258
100   $a20180420d2008      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aPharmaceutical dosage forms$iTablets
205   $a3rd ed. /$bedited by Larry L. Augsburger, Stephen W. Hoag.
210  1$aNew York :$cInforma Healthcare USA,$d2008.
215   $a1 online resource (550 p.)
300   $aDescription based upon print version of record.
311   $a1-336-10006-0 
311   $a0-8493-9015-X 
320   $aIncludes bibliographical references and index.
327   $aFront Cover; Foreword; Preface; Contents; Contributors; Chapter 1. Mass Transfer from Solid Oral Dosage Forms; Chapter 2. Approaches for Improving Bioavailability of Poorly Soluble Drugs; Chapter 3. Aims and Objectives and of Experimental Design and Optimization in Formulation and Process Development; Chapter 4. Knowledge-based Systems and Other AI Applications for Tableting; Chapter 5. Direct Compression and the Role of Filler-binders; Chapter 6. Disintegrants in Tableting; Chapter 7. Lubricants, Glidants, and Antiadherents; Chapter 8. Surfactants and Colors in Tablets
327   $aChapter 9. Orally Disintegrating Tablets and Related Tablet FormulationsChapter 10. Formulation Challenges: Multiple Vitamin and Mineral Dosage Forms; Chapter 11. Botanicals and Their Formulation into Oral Solid Dosage Forms; Chapter 12. Formulation of Specialty Tablets for Slow Oral Dissolution; Chapter 13. Formulation and Design of Veterinary Tablets; Chapter 14. Swellable and Rigid Matrices: Controlled Release Matrices with Cellulose Ethers; Chapter 15. Carrageenans in Solid Dosage Form Design; Chapter 16. Osmotic Systems; Chapter 17. Tableting of Multiparticulate Modified Release Systems
327   $aBack Cover
330   $a<b><i>Pharmaceutical Dosage Forms: Tablets, Third Edition</i></b>is acomprehensive treatment of the design, formulation, manufacture, and evaluation of the tablet dosage form.  The ultimate goal of drug product development is to design a system that maximizes the therapeutic potential of the drug substance and facilitates its access to patients; <b><i>Volume 2</i></b> focuses on the rational design, and formulation of a tablet and includes chapters with practical illustrations and formulation examples.
517 3 $aTablets
606   $aTablets (Medicine)
606   $aDrugs$xDosage forms
615  0$aTablets (Medicine)
615  0$aDrugs$xDosage forms.
676   $a615/.1901
701   $aAugsburger$b Larry L$01500692
701   $aHoag$b Stephen W$01500693
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910780603203321
996   $aPharmaceutical dosage forms$93727491
997   $aUNINA